Raymond Hohl
Director, Penn State Cancer Institute · Penn State Milton S Hershey Medical Center
Credentials: · · · · · · ·
History
PresentPenn State Cancer Institute Center · Penn State Milton S Hershey Medical Center
- 1988–1991
Hematology/Oncology University of Chicago Hospitals
- 1980–1984
Research
British Journal of Cancer · 2000 · 764 citations
Blood · 2001 · 398 citations
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer
Clinical Cancer Research · 1996 · 336 citations
22 papers · 12 as a resident
- DC
13 papers
12 papers
12 papers
11 papers
11 papers
9 papers
- KR
7 papers · 1 as a fellow
Grants
- 2002–2017
Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer
National Cancer Institute · P50
Project lead · $959.1K · University of Iowa
- 2014–2016
Targeting the Chondrosarcoma Extracellular Matrix for Drug Delivery
National Cancer Institute · R41
Contact PI · $222.9K · Terpenoid Therapeutics, Inc.
- 2005–2010
National Cancer Institute · P30
Project lead · $38.3K · University of Iowa
- 1997–1999
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $63.3K · University of Iowa
Clinical trials
- 2008–2013
Safety Study of GPX-150 in Patients With Solid Tumors
Principal investigator · Completed · Phase 1
Gem Pharmaceuticals
- 2003–2013
Principal investigator · Terminated · Phase 2
University of Iowa
- 2001–2013
Principal investigator · Terminated · Phase 1, Phase 2
University of Iowa